Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
Author Information
Author(s): K. Nishida, T. Kunisada, Z. N. Shen, Y. Kadota, K. Hashizume, T. Ozaki
Primary Institution: Okayama University
Hypothesis
Induction of differentiation and apoptosis in cancer cells by ligands of PPARγ is a novel therapeutic approach to malignant tumors.
Conclusion
Targeted therapy with PPARγ ligands could be a novel strategy against chondrosarcoma.
Supporting Evidence
- PPARγ ligands inhibited cell proliferation in a dose-dependent manner.
- 15d-PGJ2 induced apoptosis in OUMS-27 cells through a caspase-dependent pathway.
- Higher-grade chondrosarcoma expressed more antiapoptotic Bcl-xL.
Takeaway
This study shows that certain treatments can help kill cancer cells in a type of bone cancer called chondrosarcoma by making them die in a controlled way.
Methodology
The study involved treating OUMS-27 chondrosarcoma cells with PPARγ ligands and assessing cell proliferation and apoptosis through various assays.
Limitations
The effects of ligands on OUMS-27 cells were not strictly attributed to PPARγ activation.
Participant Demographics
Most patients with conventional chondrosarcoma are aged over 50 years, and it is more common in men.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website